Iveric bio, inc. (ISEE)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12
Revenues

-

-

-

-

-

-

-

-

-

-

206,654

1,661

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

1,662

-

1,668

28,198

15,721

4,782

3,448

1,597

41,678

-

39,575

-

-

-

-

-

-

-

Operating expenses:
Research and development

13,750

11,567

10,383

10,009

7,685

16,128

9,407

8,516

7,686

7,946

10,707

15,657

31,979

59,409

50,854

48,262

37,770

33,917

40,479

32,059

24,557

22,196

17,105

34,707

14,377

15,380

11,101

4,345

2,389

1,595

General and administrative

4,998

6,275

4,674

5,198

5,481

5,667

5,968

6,332

5,645

6,913

7,059

8,552

13,159

12,969

12,024

10,489

14,696

12,066

10,412

11,959

9,584

10,656

8,812

7,570

6,349

5,064

4,166

3,242

1,738

2,259

Total operating expenses

18,748

17,842

15,057

15,207

13,166

21,795

15,375

14,848

13,331

14,859

17,766

24,209

45,138

72,378

62,878

58,751

52,466

45,983

50,891

44,018

34,141

-

25,917

-

-

-

-

-

-

-

Total costs and expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

42,277

20,726

-

15,267

7,587

4,127

3,854

Loss from operations

-18,748

-17,842

-15,057

-15,207

-13,166

-21,795

-15,375

-14,848

-13,331

-14,859

188,888

-22,548

-43,476

-67,056

-61,210

-30,553

-36,745

-41,201

-47,443

-42,421

7,537

-31,168

13,658

-42,277

-20,726

-20,444

-15,267

-7,587

-4,127

-3,854

Interest income

358

369

495

617

670

677

637

602

473

409

391

344

378

403

409

446

446

387

320

139

125

-

-

72

44

0

0

-1,097

-357

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

230

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

105

-1,196

-

-

Other income

5

0

0

151

0

1

-1

0

-16

0

-12

-1

-21

122

-20

-98

30

7

19

79

-52

-

-

-

-

-

-

-

-

-

Interest income and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

73

-

-

-

-

-

-

-

Other loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

970

126

134

69

Loss before income tax provision (benefit)

-18,385

-17,473

-14,562

-14,439

-12,496

103,883

-14,739

-14,246

-12,874

-14,450

189,267

-22,205

-43,119

-66,531

-60,821

-30,205

-36,269

-40,807

-47,104

-42,203

7,610

-31,140

13,731

-42,205

-20,682

-20,389

-16,132

-10,006

-4,618

-4,153

Income tax provision (benefit)

-3,300

-9

-100

4

5

-306

6

-1,000

200

-4,896

194

-1

3

-248

70

-260

32

-5,158

-7,531

-5,072

974

-

5,179

30,785

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-15,076

-17,478

-14,437

-14,443

-12,501

104,114

-14,745

-13,209

-13,073

-9,542

189,073

-22,204

-43,122

-66,283

-60,891

-29,945

-36,301

-35,649

-39,573

-37,131

6,636

-

-

-72,990

-20,682

-20,389

-16,132

-10,006

-4,618

-4,153

Comprehensive loss

-15,076

-

-14,437

-14,443

-12,501

-

-14,745

-13,209

-13,073

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Add: accretion of preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

2,292

1,858

1,742

1,775

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,552

-

-

-20,388

-18,424

-11,864

-6,360

-5,928

Earnings Per Share, Basic and Diluted [Abstract]
Net loss per common shares - basic and diluted (in dollars per share)

-0.28

-

-0.35

-0.35

-0.30

-

-0.41

-0.37

-0.36

-

-

-0.62

-1.20

-

-

-0.85

-1.03

-

-1.14

-1.08

-

-

-

-2.19

-

-

-

-8.07

-4.33

-4.07

Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

5.26

-

-

-

-1.71

-

-

-

-

-

0.19

-

0.26

-

-0.64

-

-10.26

-

-

-

Dilutive (in dollars per share)

-

-

-

-

-

-

-

-

-

-

5.25

-

-

-

-1.71

-

-

-

-

-

0.19

-

0.25

-

-0.64

-

-10.26

-

-

-

Weighted average common shares outstanding:
Weighted average common shares outstanding - basic and dilutive (in shares)

53,426

-

41,552

41,477

41,427

-

36,202

36,188

36,153

-

-

35,858

35,804

-

-

35,392

35,256

-

34,782

34,353

-

-

-

33,373

-

-

-

1,470

1,470

1

Weighted Average Number of Shares Outstanding, Basic

-

-

-

-

-

-

-

-

-

-

35,971

-

-

-

35,594

-

-

-

-

-

34,154

-

33,531

-

32,282

-

1,795

-

-

-

Weighted Average Number of Shares Outstanding, Diluted

-

-

-

-

-

-

-

-

-

-

36,047

-

-

-

35,594

-

-

-

-

-

35,239

-

34,859

-

32,282

-

1,795

-

-

-